Equity Overview
Price & Market Data
Price: $0.0085
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $9,923,939
Volume: 0
Performance Metrics
1 Week: -0.33%
1 Month: -9.70%
3 Months: -62.77%
6 Months: -65.43%
1 Year: -78.32%
YTD: -68.97%
Company Details
Employees: 36
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United Kingdom
Details
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of severe viral lung infections that is in pre- clinical trial; and inhaled interferon beta IFN-ß, a naturally occurring protein that helps regulate the immune system to fight viruses, including coronaviruses. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.